Novo Nordisk

DividendsNovo Nordisk

NVO

With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

See below the complete and updated table with all dividends paid and declared history, etc

Excluding Date
Payment
Value ($)
Frequency
3/31/2025
4/8/2025
1,099
Biannual
8/16/2024
8/26/2024
0,517
Biannual
3/22/2024
4/2/2024
0,93
Biannual
8/18/2023
8/29/2023
0,442
Biannual
3/24/2023
4/4/2023
0,59
Biannual
8/12/2022
8/23/2022
0,289
Biannual
3/25/2022
4/5/2022
0,511
Biannual
8/16/2021
8/25/2021
0,275
Biannual
3/26/2021
4/7/2021
0,461
Biannual
8/14/2020
8/25/2020
0,259
Biannual
3/27/2020
4/7/2020
0,391
Biannual
8/16/2019
8/27/2019
0,223
Biannual
3/22/2019
4/2/2019
0,394
Biannual
8/17/2018
8/28/2018
0,231
Biannual
3/23/2018
4/3/2018
0,403
Biannual
8/17/2017
8/29/2017
0,237
Biannual
1/4